Givaudan SA

SWX:GIVN Aktierapport

Börsvärde: CHF 25.7b

Givaudan Framtida tillväxt

Future kriterier kontrolleras 2/6

Givaudan förväntas öka intäkter och intäkter med 5.4% respektive 3.9% per år. EPS förväntas tillväxt med 5.1% per år. Avkastningen på eget kapital förväntas bli 22.3% om 3 år.

Viktig information

5.4%

Tillväxttakt i vinsten

5.09%

Tillväxttakt för EPS

Chemicals vinsttillväxt8.4%
Intäkternas tillväxttakt3.9%
Framtida avkastning på eget kapital22.27%
Bevakning av analytiker

Good

Senast uppdaterad01 May 2026

Senaste uppdateringarna om framtida tillväxt

Givaudan SA (VTX:GIVN) Half-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Jul 24
Givaudan SA (VTX:GIVN) Half-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Recent updates

GIVN: Fair Outlook Balances Dividend Stability With Mixed Bank Rating Revisions

Givaudan's analyst price target is held at CHF 2,875, with minor adjustments to the discount rate, revenue growth, and profit margin assumptions reflecting a mixed set of recent analyst actions, including modest price target changes and rating shifts across major banks. Analyst Commentary Recent research on Givaudan shows a split view, with some large banks turning more constructive while several bearish analysts continue to flag risks around valuation and execution.

GIVN: Cautious Downgrades Will Support Future Margin Resilience And Re Rating Potential

Givaudan's analyst price target has been reduced from about CHF 3,748 to roughly CHF 3,447. This reflects analysts' recent rounds of target cuts and downgrades following more cautious assumptions on growth, margins and future P/E multiples.

GIVN: Fair Stance Will Balance Dividend Appeal And Cautious Bank Revisions

Givaudan's analyst price target is trimmed to CHF 2,875 from CHF 2,900 as analysts factor in more cautious assumptions about revenue growth, slightly firmer profit margins and updated P/E expectations following a series of recent target cuts across the Street. Analyst Commentary Recent Street research around Givaudan has leaned more cautious, with several bearish analysts trimming price targets and reassessing the risk and reward trade off.

GIVN: Fair Stance Will Weigh Dividend Support Against Cautious Bank Views

Analysts have trimmed their Givaudan price targets by up to several hundred CHF, reflecting slightly lower assumptions for revenue growth and profit margins while keeping fair value broadly anchored around CHF 2,900 as they adjust discount rate and P/E inputs. Analyst Commentary Recent Street research on Givaudan skews cautious, with several bearish analysts cutting price targets by CHF 150 to CHF 400 as they reset their expectations around revenue growth, margins, and the appropriate P/E to pay for the shares.

GIVN: Fair Stance Will Reflect Cautious Bank Views On Future Earnings

Analysts have lowered their price target on Givaudan to CHF 2,900 from CHF 3,100, reflecting updated assumptions around slightly higher discount rates, more cautious revenue growth, a marginally lower profit margin outlook, and a modestly reduced future P/E multiple in light of recent target cuts and a downgrade from several major banks. Analyst Commentary Recent Street research on Givaudan has tilted more cautious, with a cluster of price target cuts and at least one fresh downgrade from a major global bank.

GIVN: Chinese Pricing Pressure Will Support Future Margin Resilience And Re Rating Potential

Analysts have reduced their fair value estimate for Givaudan from CHF 3,946.93 to CHF 3,747.83. This change reflects a series of lower Street price targets and incorporates assumptions for steady revenue growth, slightly higher profit margins and a lower future P/E multiple.

Givaudan (VTX:GIVN) Is Increasing Its Dividend To CHF72.00

Feb 01
Givaudan (VTX:GIVN) Is Increasing Its Dividend To CHF72.00

GIVN: Recalibrated Valuation Support Will Sustain Outperformance Versus Chinese Pricing Pressure

Our updated analyst price target for Givaudan shifts to CHF 3,947 from CHF 4,021, as analysts factor in only modest adjustments to growth, margins, and future P/E assumptions, while recent upgrades highlight improved relative positioning and valuation support. Analyst Commentary Recent research suggests sentiment around Givaudan is improving, with upgrades linked mainly to valuation support and relative positioning versus peers, rather than big changes to fundamental assumptions.

GIVN: Fair Stance Will Reflect Resilience To Chinese Pricing Pressure

Analysts now frame their Givaudan price target at CHF 3,100, with updated assumptions reflecting a 3.9% revenue growth outlook, a 15.4% profit margin profile, and a forward P/E of about 24.5x. This view is supported by recent upgrades that highlight valuation and relative resilience versus Chinese competition and pricing pressure.

GIVN Will Face Mixed Rating Shifts Amid Intensifying Competition And Pricing Pressures

Analysts have trimmed their price target for Givaudan by CHF 100 to CHF 3,100. This reflects slightly softer assumptions for long term revenue growth and margins, even as they continue to view the company as relatively well positioned against intensifying competition and pricing pressures.

GIVN: Peer-Leading Organic Sales Will Sustain Outperformance Versus Chinese Competition

Analysts have nudged their fair value estimate for Givaudan slightly higher, from approximately CHF 3,995 to CHF 4,021. This reflects modest upgrades to long term revenue growth and profit margin assumptions as they emphasize the company’s relative resilience to Chinese competition and its peer leading organic sales growth.

Subdued Growth No Barrier To Givaudan SA's (VTX:GIVN) Price

Nov 28
Subdued Growth No Barrier To Givaudan SA's (VTX:GIVN) Price

GIVN: Peer-Leading Organic Sales Growth Will Drive Outperformance Amid Competitive Pressures

Analysts have slightly reduced their fair value estimate for Givaudan, lowering the price target from approximately CHF 4,005 to CHF 3,995. This adjustment reflects recent cautious sentiment amid ongoing pricing and competitive pressures in the sector.

Returns At Givaudan (VTX:GIVN) Are On The Way Up

Nov 12
Returns At Givaudan (VTX:GIVN) Are On The Way Up

GIVN: Peer-Leading Organic Sales Growth Will Support Share Price Recovery

Analysts have decreased their price targets for Givaudan, citing persistent challenges in the consumer chemicals sector and a cautious outlook on peer-relative performance. The targets now range from CHF 3,300 to CHF 3,725, down from previous estimates by several hundred francs.

Estimating The Intrinsic Value Of Givaudan SA (VTX:GIVN)

Oct 28
Estimating The Intrinsic Value Of Givaudan SA (VTX:GIVN)

Analysts Weigh Givaudan’s Outlook Amid CEO Transition and Adjusted Growth Forecasts

Analysts have slightly raised Givaudan's fair value estimate from CHF 3,996.53 to CHF 4,005.42. This change reflects updated expectations in light of moderated growth forecasts and cautious sentiment highlighted in recent price target revisions.

Emerging Markets And Sustainable Ingredients Will Drive Future Expansion

Givaudan's analyst price target has been revised downward from CHF 4,081.95 to CHF 3,996.53, reflecting slightly lower revenue growth expectations and profit margin forecasts according to recent analyst updates. Analyst Commentary Recent analyst activity on Givaudan has resulted in a mix of revised targets and sentiment shifts that reflect both optimism around the company's strengths and caution regarding its outlook in the current market environment.

Emerging Markets And Sustainable Ingredients Will Drive Future Expansion

Despite near-term pressures and a sector-wide derating, analysts remain positive on Givaudan's strong organic sales growth and long-term structural opportunities—particularly from regulatory-driven reformulation trends—resulting in only a marginal reduction of the consensus price target from CHF4127 to CHF4082. Analyst Commentary Givaudan is recognized for peer-leading organic sales growth, positioning it as a best-in-class flavor and fragrance company.

Here's Why We Think Givaudan (VTX:GIVN) Is Well Worth Watching

Sep 22
Here's Why We Think Givaudan (VTX:GIVN) Is Well Worth Watching

Emerging Markets And Sustainable Ingredients Will Drive Future Expansion

Analysts remain moderately optimistic on Givaudan, citing long-term benefits from regulatory-driven reformulation and market share gains tempered by near-term margin pressures and valuation concerns, resulting in an unchanged consensus price target of CHF4127. Analyst Commentary Bullish analysts expect Givaudan to benefit from industry-wide reformulation trends starting in 2026 as regulatory pressures phase out synthetic colors and ingredients, particularly in the U.S. Increases in price targets reflect confidence in Givaudan’s ability to capture incremental market share and drive organic growth amid evolving consumer preferences.

Does Givaudan (VTX:GIVN) Have A Healthy Balance Sheet?

Aug 22
Does Givaudan (VTX:GIVN) Have A Healthy Balance Sheet?

Givaudan SA (VTX:GIVN) Half-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Jul 24
Givaudan SA (VTX:GIVN) Half-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Givaudan SA's (VTX:GIVN) Price Is Out Of Tune With Earnings

Jul 17
Givaudan SA's (VTX:GIVN) Price Is Out Of Tune With Earnings

The Return Trends At Givaudan (VTX:GIVN) Look Promising

Jun 17
The Return Trends At Givaudan (VTX:GIVN) Look Promising

Here's Why We Think Givaudan (VTX:GIVN) Might Deserve Your Attention Today

May 20
Here's Why We Think Givaudan (VTX:GIVN) Might Deserve Your Attention Today
User avatar

Bloomful Splash Launch Will Drive Future Success In Fragrance & Beauty

Strategic leadership changes and portfolio expansions may drive growth in revenue and earnings.

Prognoser för vinst- och omsättningstillväxt

SWX:GIVN - Analytikernas framtida uppskattningar och tidigare finansiella data (CHF Millions )
DatumIntäkterIntäkterFritt kassaflödeKassaflöde från rörelsenGenomsnittligt Antal analytiker
12/31/20288,2481,2471,1831,67713
12/31/20277,8911,1711,1511,59518
12/31/20267,5401,0641,0591,51516
12/31/20257,4721,0711,2111,512N/A
9/30/20257,5061,0831,1631,479N/A
6/30/20257,5391,0941,1141,446N/A
3/31/20257,4761,0921,2231,536N/A
12/31/20247,4121,0901,3321,625N/A
9/30/20247,2651,0611,3491,543N/A
6/30/20247,1171,0321,3661,460N/A
3/31/20247,0169631,2321,417N/A
12/31/20236,9158931,0981,373N/A
9/30/20236,9588799011,265N/A
6/30/20237,0008657041,157N/A
3/31/20237,0598616741,053N/A
12/31/20227,117856644948N/A
9/30/20227,040818676976N/A
6/30/20226,9637807081,004N/A
3/31/20226,8248018701,146N/A
12/31/20216,6848211,0321,288N/A
9/30/20216,5798161,0191,252N/A
6/30/20216,4748111,0061,215N/A
3/31/20216,3987779851,202N/A
12/31/20206,3227439641,189N/A
9/30/20206,3267399571,222N/A
6/30/20206,3307359491,254N/A
3/31/20206,2677198831,195N/A
12/31/20196,2037028161,136N/A
9/30/20196,075687N/A1,027N/A
6/30/20195,947672N/A918N/A
3/31/20195,737668N/A917N/A
12/31/20185,527663N/A916N/A
9/30/20185,385685N/A889N/A
6/30/20185,242707N/A861N/A
3/31/20185,147714N/A861N/A
12/31/20175,051720N/A861N/A
9/30/20174,932690N/A849N/A
6/30/20174,812660N/A837N/A
3/31/20174,738652N/A821N/A
12/31/20164,663644N/A805N/A
9/30/20164,605648N/A808N/A
6/30/20164,546651N/A811N/A
3/31/20164,471638N/A863N/A
12/31/20154,396625N/A915N/A
9/30/20154,397613N/A922N/A
6/30/20154,397600N/A929N/A

Analytiker Framtid Tillväxt Prognoser

Intäkter kontra sparande: GIVN s prognostiserade vinsttillväxt ( 5.4% per år) är över sparkvoten ( 0.5% ).

Resultat vs marknad: GIVN s intäkter ( 5.4% per år) förväntas växa långsammare än marknaden för Swiss ( 10.5% per år).

Höga tillväxtresultat: GIVN s intäkter förväntas växa, men inte avsevärt.

Intäkt vs marknad: GIVN s intäkter ( 3.9% per år) förväntas växa långsammare än marknaden för Swiss ( 4.8% per år).

Hög tillväxtintäkter: GIVN s intäkter ( 3.9% per år) förväntas växa långsammare än 20% per år.

Tillväxtprognoser för vinst per aktie

Framtida avkastning på eget kapital

Framtida ROE: GIVN s avkastning på eget kapital förväntas bli hög om 3 år ( 22.3 %)

Upptäck tillväxtföretag

7D

1Y

7D

1Y

7D

1Y

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2026/05/02 05:53
Aktiekurs vid dagens slut2026/04/30 00:00
Intäkter2025/12/31
Årlig intjäning2025/12/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Givaudan SA bevakas av 37 analytiker. 18 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
Volker BosseBaader Helvea Equity Research
Konstantin WiechertBaader Helvea Equity Research
James KnightBarclays